Age-descending Phase 2 trial to assess safety and immunogenicity of a Trivalent Salmonella (S. Enteritidis, S. Typhimurium, S. Typhi Vi) Conjugate Vaccine for sub-Saharan Africa
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.